Truncal Blocks for Pediatric With Developmental Dysplasia of the Hip Undergoing Open Reduction
Developmental Dysplasia of the Hip (DDH)
About this trial
This is an interventional treatment trial for Developmental Dysplasia of the Hip (DDH) focused on measuring transversalis fascia plane block, quadratus lumborum block, ultrasound-guided, Developmental Dysplasia of the Hip, postoperative analgesia
Eligibility Criteria
Inclusion Criteria:
- Pediatric patients aged between 2 years and 10 years with DDH,
- scheduled for unilateral open reduction surgeries(Salter acetabular osteotomy,combined with proximal femoral rotation osteotomy)
Exclusion Criteria:
Patients will be excluded if they meet any of the following criteria:
- patients with known allergy to local anaesthetics,
- mental disability,
- peripheral neuropathy,
- a coagulopathy disorder,
- localized infection in the area,
- any reason cause reoperation.
Sites / Locations
- Beijing Jishuitan Hospital
- Second Affiliated Hospital of WenZhou Medical University
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Group T
Group Q
Group C
Patients in transversalis fascia plane block group(Group T) will receive ultrasound-guided transversalis fascia plane block using0.3% ropivacaine(0.8 ml/kg) after general anesthesia
Patients in quadratus lumborum block group(Group Q) will receive ultrasound-guided quadratus lumborum block using0.3%ropivacaine(0.8 ml/kg).after general anesthesia.
Patients in the third group as control (Group C)receive no nerve block.Patients will be extubated based on clinical criteria.